Friday, 17 Nov 2017

You are here

Dr. Rachel Tate: Adalimumab and Disease Remission

Dr. Rachel Tate discusses the ABILITY 3 study at the ACR/ARHP Annual Meeting in San Diego.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
ACR VIDEO

RWCS 2017: Gastroenterology Updates

21 Feb 2017

RWCS 2017: Dermatomyositis-Associated...

20 Mar 2017

RheumNow Week in Review – 16 September...

16 Sep 2016

The Week in Review: 5 February 2016

08 Feb 2016

The RheumNow Week in Review – 30 June...

30 Jun 2017

Dr. Richard Furie - Anifrolumabs...

29 Aug 2016

Dr. Jack Cush and Dr. Pete Salzmann (...

07 Nov 2017

Dr. Kathryn Dao: Early Arthritis

06 Nov 2017

RheumNow Week in Review – 7 October...

07 Oct 2016

Dr. Kathryn Dao: Steroid Duration...

06 Nov 2017

RWCS 2017: Hydralazine-Induced ANCA-...

21 Feb 2017

Alvin Wells, MD: JAK Inhibitors, Other...

08 Nov 2015